Anzeige
Mehr »
Freitag, 02.01.2026 - Börsentäglich über 12.000 News
Schon +250% im Plus - warum diese Goldstory gerade erst startet!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JWL4 | ISIN: NO0010598683 | Ticker-Symbol: HBQ
Frankfurt
30.12.25 | 13:55
0,095 Euro
+5,11 % +0,005
1-Jahres-Chart
HOFSETH BIOCARE ASA Chart 1 Jahr
5-Tage-Chart
HOFSETH BIOCARE ASA 5-Tage-Chart
RealtimeGeldBriefZeit
0,0880,13230.12.25

Aktuelle News zur HOFSETH BIOCARE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.12.25Hofseth BioCare ASA: Cancellation of Subsequent Offering - Update on completion of Private Placement1
HOFSETH BIOCARE Aktie jetzt für 0€ handeln
03.12.25Hofseth BioCare ASA: Financial calendar-
21.11.25Hofseth BioCare ASA: PRIMARY INSIDER NOTIFICATION3
21.11.25Hofseth BioCare ASA: RESULTS OF SUBSEQUENT OFFERING2
20.11.25Hofseth BioCare ASA: Extraordinary General Meeting completed2
20.11.25Hofseth BioCare ASA: LAST DAY OF SUBSCRIPTION PERIOD IN SUBSEQUENT OFFERING3
20.11.25Hofseth BioCare ASA: HBC ANNOUNCES STRATEGIC PRODUCT PARTNERSHIP WITH JAMES LAVALLE & METABOLIC ELITE-
10.11.25Hofseth BioCare ASA: Publication of the Prospectus - Start of the Subscription Period for the Subsequent Offering2
07.11.25Hofseth BioCare ASA: Terms of the Subsequent Offering-
07.11.25Hofseth Biocare ASA: Third Quarter 2025 Financial Report124HBC recorded total operating revenues of NOK 54.9 million in the third quarter of 2025, compared to NOK 67.9 million in the same period last year. Net operating revenues were NOK 54.8 million, reflecting...
► Artikel lesen
30.10.25Hofseth BioCare ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING3
28.10.25XFRA CAPITAL ADJUSTMENT INFORMATION - 28.10.2025234Das Instrument 5YW CA07135M2031 BATTERY X METALS INC. EQUITY wird ex Kapitalmassnahme gehandelt am 28.10.2025 The instrument 5YW CA07135M2031 BATTERY X METALS INC. EQUITY is traded ex capital adjustment...
► Artikel lesen
27.10.25Hofseth BioCare ASA: Mandatory Notification of Trade2
27.10.25Hofseth BioCare ASA: Private placement successfully placed7
27.10.25Hofseth BioCare ASA: Disclosures of Large Shareholdings 3
27.10.25Hofseth Biocare ASA: Ex. Subsequent Offering Today2
27.10.25Hofseth BioCare ASA: Key Information Relating to Subsequent Offering2
24.10.25Hofseth Biocare ASA: USD 5 Million Divestment in Aecorbio164NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION...
► Artikel lesen
24.10.25Hofseth BioCare ASA: Contemplated Private Placement and Partial Divestment of Shares in Aecorbio349NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION...
► Artikel lesen
17.09.25Hofseth Biocare ASA: AECORBIO SECURES A FURTHER $1.5M AT A $30M VALUATION FOR ONGOING FT-002A PEPTIDE DEVELOPMENT IN PROSTATE CANCER9
Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1